# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Yellow fever

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 11 results.
Non- Inferiority Fractional-doses Trial for Yellow Fever Vaccine
Status: Not yet recruiting
Last Changed: Aug 16, 2019
First Received: Aug 16, 2019
Disease(s): Yellow Fever
Intervention(s): Yellow fever vaccine, Institut Pasteur
Locations: KEMRI-Wellcome Trust Research Programme, Kilifi, Coast, Kenya
Epicentre, Mbarara., Mbarara, Uganda
A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever
Status: Not yet recruiting
Last Changed: Mar 27, 2019
First Received: Mar 27, 2019
Disease(s): Yellow Fever
Intervention(s): Galidesivir, Placebo
Locations: Clinical Research Unit and Department of Infectious and Parasitic Diseases Hospital das Clínicas, School of Medicine, USP, São Paulo, SP, Brazil
Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines (YEFE)
Status: Recruiting
Last Changed: Aug 14, 2019
First Received: Dec 13, 2016
Disease(s): Yellow Fever
Intervention(s): Stamaril, Sanofi Pasteur, Yellow fever vaccine, Bio-Manguinhos, Yellow fever vaccine, Institut Pasteur, Yellow fever vaccine, Chumakov Institute, Yellow fever vaccine, Chumakov Institute, Yellow fever vaccine, Chumakov Institute
Locations: KEMRI, Kilifi, Kenya
Epicentre, Mbarara, Uganda
"Persistence of Neutralizing Antibodies Against Yellow Fever (YF) in HIV-infected Patients"
Status: Recruiting
Last Changed: Jul 18, 2018
First Received: Jul 18, 2018
Disease(s): HIV Infections, Yellow Fever Vaccine
Intervention(s): Yellow fever neutralizing antibodies measure
Locations: Instituut voor Tropische Geneeskunde, Antwerp, Belgium
AZ Sint-Jan Brugge, Brugge, Belgium
Centre Hospitalier Universitaire Saint-Pierre, Brussels, Belgium
Hôpital Erasme, Brussels, Belgium
Cliniques Universitaires Saint-Luc, Brussels, Belgium
... and 8 other locations.
Immunogenicity of Fractional One-fifth and One-half Doses of Yellow Fever Vaccine Compared to Full Dose in Children 9-23 Months Old
Status: Not yet recruiting
Last Changed: Oct 31, 2018
First Received: Oct 31, 2018
Disease(s): Yellow Fever
Intervention(s): Yellow Fever 17DD Vaccine
Dose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in Adults
Status: Recruiting
Last Changed: Nov 20, 2019
First Received: Oct 29, 2019
Disease(s): Yellow Fever (Healthy Volunteers)
Intervention(s): Yellow fever vaccine (produced on serum-free Vero cells), Dosage 1 vYF vaccine, Yellow fever vaccine (produced on serum-free Vero cells), Dosage 2 vYF vaccine, Yellow fever vaccine (produced on serum-free Vero cells), Dosage 3 vYF vaccine, Yellow fever vaccine
Locations: Investigational Site Number 8400001, Silver Spring, Maryland, United States
Yellow Fever Vaccine on Statin/ Non Statin Subjects
Status: Recruiting
Last Changed: Apr 19, 2018
First Received: Apr 17, 2017
Disease(s): Yellow Fever Vaccine, Yellow Fever
Intervention(s): Stamaril (live attenuated yellow fever vaccine)
Locations: SingHealth Investigational Medicine Unit, Singapore, Singapore
Cytotoxicity of Yellow Fever Specific CD8 T Cells Following YF-17D Vaccination
Status: Recruiting
Last Changed: Sep 13, 2019
First Received: Sep 10, 2019
Disease(s): Healthy, Cytotoxicity, Yellow Fever Vaccination Reaction
Intervention(s): Yellow Fever Vaccine
Locations: Aarhus University Hospital, Aarhus, Denmark
Investigation of Serious Adverse Events Following Vaccination Against Yellow Fever: Emphasis on Genetic Basis and Biological Markers
Status: Recruiting
Last Changed: May 13, 2019
First Received: May 06, 2019
Disease(s): Drug-Related Side Effects and Adverse Reactions
Locations: Assessoria Clinica / Bio-Manguinhos / Fiocruz, Rio De Janeiro, RJ, Brazil
Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals
Status: Recruiting
Last Changed: Jul 30, 2018
First Received: Apr 27, 2017
Disease(s): HIV Infections
Intervention(s): Yellow Fever vaccination (17 DD Biomanguinhos)
Locations: Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil